The company's last Venture Round investment, which took place on 03 November 2016, was secured from Enterprise Ireland. OrthoXel plans to advance the Apex Tibial Nailing system through regulatory approval and clinical studies in early 2017, followed by the Apex Femoral Nailing system. This innovative product, backed by rigorous testing and supported by an investment from Enterprise Ireland, positions Orthoxel as a promising player in the biotechnology and healthcare industries.
Orthoxel
Introducing a novel intramedullary nail designed for optimal treatment of tibia and femoral fractures, backed by extensive R&D and rigorous testing.
Founded 2014
11-50 employees
Series Unknown
Biotechnology, Health Care
General Information
Get notified when Orthoxel moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Orthoxel
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Orthoxel
Taxonomy: Orthopedic Trauma, Tibial Nail System, Femoral Nail System, Orthopaedic Surgery, Surgical Implants, Fracture Fixation, Intramedullary Nailing, Clinical Study, Start-up, Orthopedic Research, R&D, Trauma Devices
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | •••••• | 1 |
|
03 Nov 2016 |
Orthoxel Alternatives & Competitors
Orthoxel vs
Pioneering the future of orthopedic trauma treatment with a specialized intramedullary nailing syste...
Debt Financing
1 employees
Biotechnology, Health Care
Orthoxel vs
Empowering surgeons with innovative solutions for advanced arthroscopic procedures.
Series Unknown
Health Care, Medical Devices
Orthoxel vs
Crafting Advanced Solutions for Tibial Fracture Treatment
Series Unknown
2-10 employees
Health Care, Medical Devices
FAQ About Orthoxel
Introducing a novel intramedullary nail designed for optimal treatment of tibia and femoral fractures, backed by extensive R&D and rigorous testing.
Orthoxel was founded in 2014.
Orthoxel operates in the following industries: Biotechnology, Health Care.
Orthoxel has approximately 11-50 employees.
Orthoxel has completed 1 funding round. The latest funding stage is Series Unknown.
Top alternatives and competitors to Orthoxel include DGIMED ORTHO, Cayenne Medical, Intelligent Orthopaedics, Apex Innovative Sciences, Metalogix. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orthoxel and DGIMED ORTHO are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Orthoxel and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.